Physician initiated, prospective, non-randomized Multicenter trial, investigating the safety and Efficacy of the tReatment with Luminor DCB and Angiolite BTK DES in TASC C and D tibial Occlusive disease iN patients with critical limb ischaemia at 12-month follow up.
Device : Luminor 14m & Angiolite BTK as bailout stenting.
1 year outcomes: 81.6% Ftlr – 74% AFS – 69.4% PP
